Categories
Price: | Negotiable/Piece |
---|---|
Trade Terms: | FOB,CIF |
Min Order: | 100boxes |
Pay Type: | T/T,Western Union |
Product: | Cefepime Hydrochloride for Injection |
Ingredients | The main ingredients of cefepime hydrochloride, its chemical name: 1 - [[(6R, 7R) -7- [2- (2- amino-4-thiazolyl) - acetaldehyde amido] -2- - carboxy-8-oxo-5-thia-1-azabicyclo [4.2.0] oct-2-en-3-yl] methyl] -1-methyl-pyrrolidin chloride, 72- (Z ) - (O- methyloxime), hydrochloric acid, monohydrate |
Formula | C19H25ClN6O5S2 ? HCl ? H2O |
Molecular Weight | 571.5 |
Properties | white to pale yellow powder. |
Indications | It can be used to treat adults and children aged 2 months to 16 above-sensitive bacteria that cause moderate to severe infections, including lower respiratory tract infections (pneumonia and bronchitis), urinary tract infections and SIMPLE complicated urinary tract infections (including pyelonephritis nephritis), uncomplicated skin and skin and soft tissue infections, complicated intra-abdominal infections (including peritonitis and biliary tract infections), obstetrics and gynecology infections, sepsis, and neutropenia with experience in the treatment of fever patients. It can also be used in children with bacterial meningitis. |
Adverse reactions | This product is generally well tolerated, side effects are mostly mild and transient, discontinuation of treatment rare. Common adverse reactions associated with the product can mainly diarrhea, rash, and injection site reactions, such as phlebitis, injection site pain and inflammation. Other adverse effects include nausea, vomiting, allergies, itching, fever, paresthesia and headache. When adjusted in patients with renal insufficiency without cefepime dosage, can cause encephalopathy, muscle spasms, seizures. In case of treatment-related epilepsy, medication should be stopped, if necessary, should be carried out anticonvulsant therapy. The treatment of children with meningitis product, occasional convulsions, drowsiness, nervousness and headaches, mainly meningitis caused no significant relationship with the product. |
Taboo | The product is contraindicated in cefepime or L- arginine, cephalosporins, penicillins, or other β- lactam antibiotics, patients with immediate allergic reactions. |
NOTES | Before using, you should determine whether the patient has cefepime, other cephalosporins, penicillins other β- lactam antibiotics or allergies. For any allergies, especially in patients with a history of drug allergy should be cautious. |
Pregnant and lactating women | Although animal reproductive toxicity and teratogenicity tests showed no teratogenic cefepime and embryo toxicity, but no clinical data for this product is adequate and well-controlled pregnant women and women in childbirth. Therefore, this product should be used with caution in pregnant women. |
Prod Model: | PI0017 |
---|---|
Markets: | North America,South America,Eastern Europe,Southeast Asia,Africa,Oceania,Mid East,Eastern Asia,Western Europe |
Type: | Organic Chemicals |
Pharmaceutical Technology: | Chemical Synthesis |